Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 26, Issue 22, pp. 5887-5894
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 10, 2020
- Revision received June 18, 2020
- Accepted July 15, 2020
- Published first July 21, 2020.
Article Versions
- Previous version (July 21, 2020 - 05:04).
- Previous version (October 6, 2020 - 05:38).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Akihito Kawazoe1,
- Yasutoshi Kuboki1,
- Eiji Shinozaki2,
- Hiroki Hara3,
- Tomohiro Nishina4,
- Yoshito Komatsu5,
- Satoshi Yuki6,
- Masashi Wakabayashi7,
- Shogo Nomura7,
- Akihiro Sato7,
- Takeshi Kuwata8,
- Masahito Kawazu9,
- Hiroyuki Mano9,
- Yosuke Togashi10,
- Hiroyoshi Nishikawa10, and
- Takayuki Yoshino1,*
- 1Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
- 2Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
- 3Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
- 4Department of Gastrointestinal Medical Oncology, Shikoku Cancer Center, Matsuyama, Japan.
- 5Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Hokkaido, Japan.
- 6Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Hokkaido, Japan.
- 7Clinical Research Support Office, National Cancer Center Hospital East, Chiba, Japan.
- 8Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan.
- 9Division of Cellular Signaling, National Cancer Center, Tokyo, Japan.
- 10Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Chiba, Japan.
- ↵*Corresponding Author:
Takayuki Yoshino, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. Phone: 81-47-133-1111; Fax: 81-47-131-4724; E-mail: tyoshino{at}east.ncc.go.jp
November 2020
Volume 26, Issue 22
Volume 26, Issue 22
Multicenter Phase I/II Trial of Napabucasin and Pembrolizumab in Patients with Metastatic Colorectal Cancer (EPOC1503/SCOOP Trial)
Jump to section
Advertisement